REFERENCES
- J. Tomaszewski and M. M. Rumore, Stereoisomeric drugs: FDA's policy statement and the impact on drug development, Drug Dev. Ind. Pharm., 20, 119–139(1994).
- A. A. Abdel-Rahman, A. E. Aboutaleb, A. Stamm, E. M. Samy, and S. I. Abdel-Rahman, Accelerated stability of ibuprofen-Eudragit RSPM sustained release tablets, IR and DSC solid stability testing, J. Pharm. Belg., 48, 463–470(1993).
- D. D. Chow and A. H. Karara, Characterization, dissolution and bioavailability in rats of ibuprofen-β-cyclodextrin complex system, Int. J. Pharm., 28, 95–101(1986).
- S. I. F. Badawy, M. M. Ghorab, and C. M. Adeyeye, Bio availability of danazol-hydroxypropyl-β-cyclodextrin complex by different routes of administration, Int. J. Pharm., 145, 137–143(1996).
- C. M. Kunz, M. Vakily, and F. Jamali, Stereoselective release of racemic drugs in the presence of chiral excipients, Pharm. Res., 11 (10), S305 (1994).
- S. P. Duddu, M. Vakilynejad, F. Jamali, and D. J. W. Grant, Stereoselective dissolution of propanolol hydrochloride from hydroxypropyl methylcellulose matrices, Pharm. Res., 10 (11), 1648–1653(1993).
- L. Maggi, G. Massolini, E. Delorenzi, U. Conte, and G. Caccialanza, Evaluation of stereoselective dissolution of verapamil hydrochloride from matrix tablets press-coated with chiral excipients, Int. J. Pharm., 136(1–2), 43–51(1996).
- A. M. Healy and O. I. Corrigan, Predicting the dissolution rate of ibuprofen-acidic excipient compressed mixtures in reactive media, Int. J. Pharm., 84, 167–173(1992).
- T. Backensfeld, B. W. Muller, and K. Kolter, Interaction of NSA with cyclodextrins and hydroxypropyl cyclodextrin derivatives, Int. J. Pharm., 74, 85–93(1991).
- Y. Kawashima, T. Iwamoto, T. Niwa, H. Takeuchi, and Y. Itoh, Preparation and characterization of a new con trolled release ibuprofen suspension for improving suspendability, Int. J. Pharm., 75, 25–36(1991).
- F. A. Menard, M. G. Dedhiya, and C. T. Rhodes, Potential pharmaceutical applications of a new beta cyclodextrin derivative, Drug Dev. Ind. Pharm., 14 (11), 1529–1547(1988).
- G. Bettinetti, A. Gazzaniga, P. Mura, F. Giordano, and M. Setti, Thermal behavior and dissolution properties of naproxen in combinations with chemically modified beta-cyclodextrin, Drug Dev. Ind. Pharm., 18 (1), 39–53(1992).
- C. M. Adeyeye and J. C. Price, Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax micro spheres, J. Microencapsulation, 14 (3), 357–377(1997).
- R. K. Janjikhel and C. M. Adeyeye, Stereospecific formulation and characterization of sustained release ibuprofen microspheres, J. Microencapsulation, 14 (4), 409–426(1997).
- C. H. Lemko, G. Caille, and R. T. Foster, Stereospecific high performance liquid chromatographic assay of ibuprofen: improved sensitivity and sample processing efficiency, J. Chromatogr., 619, 330–335(1993).
- M. R. Wright, S. Sattari, D. R. Brocks, and F. Jamali, Improved HPLC assay method for enantiomers of ibuprofen, J. Chromatogr., 583, 259–265(1992).
- C. M. Adeyeye and F. F. Chen, Stereoselective disposition of suspensions of conventional and wax matrix sustained release ibuprofen microspheres in rats, Pharm. Res., 14 (12), 1810–1815(1997).